Page 1 of Clinical Trials for Schering-Plough [SPONSOR-COLLABORATORS], 737 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
Last Updated: April 14, 2011
Condition(s): Hypercholesterolemia; Coronary Arteriosclerosis
2
Terminated
Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)
Last Updated: March 24, 2011
Condition(s): Hepatitis C, Chronic
3
Completed
Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)(COMPLETED)
Last Updated: October 2, 2009
Condition(s): Anesthesia, General
4
Completed
A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)
Last Updated: March 11, 2011
Condition(s): Asthma; COPD
5
Completed
To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Engage)(Study 38819AM1)(COMPLETED)(P05787)
Last Updated: October 2, 2009
Condition(s): In Vitro Fertilization
6
Completed
Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)
Last Updated: June 28, 2011
Condition(s): Hepatitis C, Chronic
7
Completed
Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550 AM3)
Last Updated: May 19, 2011
Condition(s): Parkinson Disease
8
Recruiting
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
Last Updated: February 29, 2012
Condition(s): Parkinson's Disease
9
Completed
Study to Evaluate the Safety and Dose-Range of SCH 527123 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (Study P04592AM4)(COMPLETED)
Last Updated: October 16, 2009
Condition(s): Chronic Obstructive Pulmonary Disease
10
Completed
A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612AM4)(COMPLETED)
Last Updated: January 27, 2011
Condition(s): Psoriasis
11
Terminated
The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633AM1)(TERMINATED)
Last Updated: October 21, 2010
Condition(s): Coronary Artery Bypass; Myocardial Infarction; Ventricular Dysfunction, Left; Stroke; Cardiopulmonary Bypass
12
Withdrawn
Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451-AM1)
Last Updated: January 24, 2011
Condition(s): Ankylosing Spondylitis
13
Completed
Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)(COMPLETED)
Last Updated: March 17, 2010
Condition(s): Hypercholesterolemia
14
Completed
Neutrophilic Asthma Study With SCH 527123 (Study P05365AM2)(COMPLETED)
Last Updated: September 30, 2009
Condition(s): Neutrophilic Asthma
15
Terminated
Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146AM4)
Last Updated: February 23, 2012
Condition(s): Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Carcinoma, Large Cell; Carcinoma, Squamous Cell
16
Completed
Trial to Assess the Safety and Effects of SCH 530348 in Japanese Subjects With Acute Coronary Syndrome (P04772)(COMPLETED)
Last Updated: October 21, 2009
Condition(s): Atherosclerosis; Myocardial Ischemia; Myocardial Infarction
17
Completed
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Last Updated: August 12, 2010
Condition(s): Allergies
18
Completed
Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Subjects With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)(COMPLETED)
Last Updated: April 13, 2010
Condition(s): Primary Hypercholesterolemia; Mixed Hyperlipidemia
19
Completed
A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)(MK-0887A-178-0)
Last Updated: November 21, 2011
Condition(s): Asthma
20
Active, not recruiting
The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160 AM2)
Last Updated: May 1, 2012
Condition(s): Chronic Hepatitis C Genotype 1

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Schering-Plough

Page 1 of Clinical Trials for Schering-Plough [SPONSOR-COLLABORATORS], 737 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About